Sepracor, Inc. to Cut 20 Percent of Workforce

NEW YORK, Jan 28 (Reuters) - Sepracor Inc, maker of the Lunesta sleep drug, said on Wednesday it would cut about 20 percent of its workforce, or 530 jobs, in an effort to save some $210 million in expenses, and its shares jumped 17 percent.